Catheter Precision Announces Director Departure and Election
Ticker: VTAK · Form: 8-K · Filed: Jan 7, 2025 · CIK: 1716621
| Field | Detail |
|---|---|
| Company | Catheter Precision, Inc. (VTAK) |
| Form Type | 8-K |
| Filed Date | Jan 7, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $200,000, $0.53 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-departure, board-election, officer-compensation
TL;DR
Board shakeup at Catheter Precision: Leo out, Smith in.
AI Summary
On January 4, 2025, Catheter Precision, Inc. announced the departure of Director Dr. David E. Leo and the election of Dr. Robert L. Smith as a new director. The company also disclosed information regarding compensatory arrangements for certain officers.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director departures and board changes can introduce uncertainty regarding leadership and strategic direction.
Key Players & Entities
- Catheter Precision, Inc. (company) — Registrant
- Dr. David E. Leo (person) — Departing Director
- Dr. Robert L. Smith (person) — Elected Director
- January 4, 2025 (date) — Date of earliest event reported
FAQ
Who is Dr. David E. Leo and why did he depart from the board?
Dr. David E. Leo was a Director of Catheter Precision, Inc. The filing does not specify the reason for his departure.
Who is Dr. Robert L. Smith and what is his background?
Dr. Robert L. Smith has been elected as a new director to the board of Catheter Precision, Inc. Specific background details are not provided in this filing.
What other items are being reported in this 8-K filing?
In addition to director changes, the filing also covers Unregistered Sales of Equity Securities and Compensatory Arrangements of Certain Officers.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on January 4, 2025.
What is the state of incorporation for Catheter Precision, Inc.?
Catheter Precision, Inc. is incorporated in Delaware.
Filing Stats: 820 words · 3 min read · ~3 pages · Grade level 11.9 · Accepted 2025-01-07 16:15:24
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VTAK NYSE American Indic
- $200,000 — tion package: an annual base salary of $200,000, paid in accordance with the Company's
- $0.53 — over 3 years, with an exercise price of $0.53 per share and a term of 10 years; and
Filing Documents
- catheter_8k.htm (8-K) — 26KB
- 0001654954-25-000174.txt ( ) — 148KB
- catheter-20250104.xsd (EX-101.SCH) — 6KB
- catheter-20250104_lab.xml (EX-101.LAB) — 14KB
- catheter-20250104_cal.xml (EX-101.CAL) — 1KB
- catheter-20250104_pre.xml (EX-101.PRE) — 9KB
- catheter-20250104_def.xml (EX-101.DEF) — 2KB
- catheter_8k_htm.xml (XML) — 4KB
02 Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities With respect to the stock option grant to Mr. Anderson described below, the information contained in Item 5.02 is incorporated herein by reference. The stock options were issued pursuant to the exemption contained in Section 4(a)(2) of the Securities Act of 1933, as amended, as an inducement to Mr. Anderson to accept the Company's offer of employment. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Philip Anderson as Chief Financial Officer. On January 4, 2025, the Board of Directors of Catheter Precision, Inc. (the "Company") appointed Philip Anderson as Chief Financial Officer of the Company, effective January 6, 2025. Mr. Anderson was also designated as the Company's Principal Financial Officer and Principal Accounting Officer for Securities and Exchange Commission ("SEC") reporting purposes. Ms. Margrit Thomassen, the Company's previous Interim Chief Financial Officer, ceased serving in that capacity on January 6, 2025 and will continue in the role of Company Controller. Mr. Anderson was retired from November 2022 to December 2024. He served as the Chief Financial Officer of Heritage Distilling Corporation, an adult beverage distiller, from August 2021 to November 2022 . From August 2020 to June 2021, he served as Chief Financial Officer of Crown Electrokinetics Corp., a pre-revenue technology/hardware company in the areas of smart windows, fiber optics and water quality solutions. He served as Chief Financial Officer of Kubient, Inc., a supplier of fraud detection and prevention solutions to the global digital advertising market, from June 2019 to January 2020 . He received a Bachelor of Arts in Business Management from Ithaca College and an MBA with concentration in Finance from Hofstra University. In connection with his appointment, Mr. Anderson received the following compensatio
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: January 7, 2025 By: /s/ David A. Jenkins David A. Jenkins Executive Chairman of the Board and Chief Executive Officer 3